Income Statement (TTM)
StageZero Life Sciences Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 4 | 7 | 7 | 6 | 5 | 4 | 5 | 5 | 4 | 3 | 3 | 3 |
| Change (%) | 158.04 | 58.90 | 5.17 | -11.24 | -17.71 | -22.81 | 15.17 | 2.55 | -17.87 | -14.29 | -6.81 | -4.91 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 2 | 3 | 4 | 5 | 5 | 4 | 4 | 5 | 5 | 4 | 3 | 3 | 3 |
| Change (%) | 98.35 | 20.63 | 10.93 | -1.71 | -14.42 | 11.01 | 13.07 | -2.87 | -11.48 | -22.20 | -9.50 | -3.52 | |
| % of Revenue | 108.30 | 83.25 | 63.20 | 66.66 | 73.81 | 76.77 | 110.39 | 108.38 | 102.65 | 110.64 | 100.43 | 97.54 | 98.96 |
| Gross Operating Profit | -0 | 1 | 2 | 2 | 2 | 1 | -0 | -0 | -0 | -0 | -0 | 0 | 0 |
| Change (%) | -620.96 | 249.07 | -4.72 | -30.29 | -26.99 | -134.53 | -7.12 | -67.54 | 229.39 | -96.53 | -632.93 | -59.86 | |
| % of Revenue | -8.30 | 16.75 | 36.80 | 33.34 | 26.19 | 23.23 | -10.39 | -8.38 | -2.65 | -10.64 | -0.43 | 2.46 | 1.04 |
| SG&A | 3 | 4 | 5 | 7 | 7 | 8 | 9 | 9 | 8 | 7 | 6 | 5 | 4 |
| Change (%) | 39.08 | 24.49 | 29.15 | 9.10 | 13.20 | 8.44 | -4.73 | -5.35 | -14.54 | -13.27 | -16.26 | -11.71 | |
| % of Revenue | 188.28 | 101.48 | 79.51 | 97.64 | 120.01 | 165.07 | 231.89 | 191.82 | 177.04 | 184.21 | 186.42 | 167.52 | 155.55 |
| R&D | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | |
| Change (%) | 0.00 | 32.69 | 78.49 | 49.54 | 16.35 | 13.60 | -12.54 | -60.69 | -18.64 | -38.69 | -45.38 | ||
| % of Revenue | 5.27 | 3.31 | 4.18 | 8.41 | 15.28 | 23.03 | 22.72 | 19.38 | 9.27 | 8.80 | 5.79 | 3.33 | |
| OpEx | 5 | 8 | 10 | 12 | 12 | 13 | 14 | 15 | 14 | 12 | 10 | 8 | 7 |
| Change (%) | 63.27 | 21.87 | 21.60 | 6.54 | 4.63 | 9.68 | 1.80 | -5.02 | -16.48 | -16.68 | -14.63 | -9.48 | |
| % of Revenue | 300.29 | 190.00 | 145.72 | 168.48 | 202.23 | 257.12 | 365.32 | 322.92 | 299.07 | 304.13 | 295.66 | 270.85 | 257.83 |
| Operating Income | -3 | -4 | -3 | -5 | -6 | -8 | -10 | -10 | -9 | -8 | -6 | -5 | -5 |
| Change (%) | 15.95 | -19.28 | 57.52 | 32.52 | 26.48 | 30.35 | -3.23 | -8.42 | -15.78 | -17.85 | -18.62 | -12.16 | |
| % of Revenue | -200.29 | -90.00 | -45.72 | -68.48 | -102.23 | -157.12 | -265.32 | -222.92 | -199.07 | -204.13 | -195.66 | -170.85 | -157.83 |
| Interest Expense | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -21.32 | -21.08 | -8.67 | -89.58 | 301.38 | -10.22 | -0.26 | 14.56 | 38.24 | 34.05 | 13.63 | -9.82 | |
| % of Revenue | -52.47 | -16.00 | -7.95 | -6.90 | -0.81 | -3.95 | -4.60 | -3.98 | -4.45 | -7.49 | -11.71 | -14.27 | -13.54 |
| Net Income | -6 | -7 | -12 | -7 | -7 | -7 | -1 | -6 | -4 | -11 | -13 | -12 | -13 |
| Change (%) | 15.94 | 70.81 | -39.26 | -5.77 | 11.53 | -89.61 | 721.31 | -34.07 | 170.97 | 10.70 | -6.97 | 6.61 | |
| % of Revenue | -367.97 | -165.32 | -177.71 | -102.63 | -108.96 | -147.67 | -19.88 | -141.80 | -91.17 | -300.79 | -388.51 | -387.86 | -434.85 |
Source: Capital IQ
